Halliburton Company
NYSE:HALOil & Gas Equipment & Services
-$1.44 today
- Market cap
- $26.00B
- Beta
- 0.70
- P/E (TTM)
- 18.9
- EPS (TTM)
- $1.84
- Dividend yield
- 1.95%
Volume 7.42M
Average 13.49M
HAL Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Halliburton CompanyNYSE: HAL
Research & Development · Q3 FY2026 · quarter ended Sep 2026
Research & development remains negative
Q3 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $411M. Over 3 fiscal years it compounded at +6.0% a year.
Context
- Research & development amounted to 1.9% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $102.75M.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 411M USD
- Year-over-year change
- -3.5%
- 4-year CAGR
- +6.4%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 411M | -3.5% |
| FY2024 | 2024-12-31 | 426M | +4.4% |
| FY2023 | 2023-12-31 | 408M | +18.3% |
| FY2022 | 2022-12-31 | 345M | +7.5% |
| FY2021 | 2021-12-31 | 321M | — |
Research & Development vs competitors
How HAL compares with its peers on the latest reported figures
- HAL's LTM Sep 2026 research & development of $411M is the 3rd highest of the 11 companies compared; the peer median is $850K.
- Its year-over-year change of -3.5% is the 4th highest of 6, against a peer median of -3.5%.
- Research & development amounts to 1.8% of revenue for HAL, versus a peer median of 0.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $678M | -5.0% | +3.8% | 1.8% | |
| LTM Jun 2026 | $569M | +85.3% | +2.6% | 2.1% | |
| LTM Sep 2026 | $411M | -3.5% | +6.0% | 1.8% | |
| LTM Jun 2026 | $93.4M | -3.5% | +7.4% | 0.9% | |
| LTM Sep 2026 | $21M | -75.0% | — | 0.4% | |
| LTM Mar 2026 | $1.7M | +13.3% | +41.5% | 0.3% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding HAL) | $850K | -3.5% | +5.6% | 0.1% | |
Competitors are the stored peer set for HAL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 15.3B | 20.3B | 23.02B | 22.94B | 22.18B |
| Cost of Revenue | 13.28B | 17.05B | 18.66B | 18.64B | 18.7B |
| Gross Profit | 2.02B | 3.24B | 4.36B | 4.3B | 3.48B |
| Gross Margin | 13.2% | 16.0% | 18.9% | 18.7% | 15.7% |
| Research & Development | 321M | 345M | 408M | 426M | 411M |
| Selling, General & Admin | 204M | 240M | 226M | 239M | 239M |
| Operating Expenses | 216M | 536M | 277M | 479M | 1.22B |
| Depreciation & Amortization | 904M | 940M | 998M | 1.08B | 1.14B |
| EBITDA | 2.65B | 3.94B | 4.94B | 5.01B | 4.12B |
| EBITDA Margin | 17.3% | 19.4% | 21.5% | 21.8% | 18.6% |
| Operating Income | 1.8B | 2.71B | 4.08B | 3.82B | 2.26B |
| Operating Margin | 11.8% | 13.3% | 17.7% | 16.7% | 10.2% |
| Interest Income | 9M | 29M | 81M | 97M | 0 |
| Interest Expense | 529M | 492M | 578M | 353M | 352M |
| Other Income / Expenses | (548M) | (597M) | (720M) | (588M) | (489M) |
| Income Before Tax | 1.25B | 2.11B | 3.36B | 3.23B | 1.77B |
| Pre-Tax Margin | 8.2% | 10.4% | 14.6% | 14.1% | 8.0% |
| Income Tax Expense | (216M) | 515M | 701M | 718M | 479M |
| Net Income | 1.46B | 1.57B | 2.64B | 2.5B | 1.28B |
| Net Margin | 9.5% | 7.7% | 11.5% | 10.9% | 5.8% |
| EPS (Basic) | 1.63 | 1.74 | 2.93 | 2.83 | 1.51 |
| EPS (Diluted) | 1.63 | 1.73 | 2.92 | 2.83 | 1.50 |
| Weighted Avg Shares | 892M | 904M | 899M | 882M | 839M |
| Weighted Avg Shares (Diluted) | 892M | 908M | 902M | 883M | 840M |
Halliburton Company
NYSE:HAL
Intrinsic Alpha fair value
Locked
Current Price
$31.44
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.